Caliper forges strategic partnership with Seegene
Caliper Life Sciences president and CEO Kevin Hrusovsky said the deal will improve the economics of diagnostic testing and advance the worldwide implementation of personalised medicine. "We believe
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.